Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person has been diagnosed with Crohn's disease based on a specific 2019 set of guidelines used for children with inflammatory bowel disease.
- The person has a disease activity score of 30 or higher on a standard scale used to measure Crohn's disease severity in children (called the PCDAI).
- The person has never previously been treated with certain immune-suppressing or anti-inflammatory medicines, specifically azathioprine, 6-mercaptopurine, or anti-TNF biologic drugs.
- The person may be taking certain other supportive treatments — such as acid-reducing medicines (at a stable dose for at least 2 weeks before joining) or tube feeding/nutritional supplements (on a stable plan for at least 2 weeks) — as long as steroid treatments (whether by mouth, into a vein, or as a rectal treatment) have been fully stopped for at least 2 weeks before joining.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- The person has short bowel syndrome, has had ostomy surgery, has a narrowing of the bowel causing symptoms, has an abscess, or has had abdominal surgery within the past 6 months.
- The person has a history of tuberculosis or similar infections, or has shown signs of these on a chest scan or a skin test.
- The person has had a serious opportunistic infection in the past 6 months, or has active hepatitis B or C, or has HIV.
- The person has multiple sclerosis or cancer.
- The person has certain inherited gene changes (specifically, two copies of a mutation in the NUDT15 or TPMT gene, or at least one copy of a mutation in either of these genes) that affect how certain medicines are processed by the body (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13867467021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The clinical remission rates（(Pediatric Crohn's Disease Activity Index）in the 14th week and the 54th week
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.